(Q42860766)

8 November 2017

BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up (English)

1 reference

8 November 2017

1 reference

Rani H Singh

1

1 reference

8 November 2017

Meghan E Quirk

series ordinal

2

1 reference

8 November 2017

Teresa D Douglas

series ordinal

3

1 reference

8 November 2017

Mary C Brauchla

series ordinal

4

1 reference

8 November 2017

13 October 2010

1 reference

Journal of Inherited Metabolic Disease

8 November 2017

1 reference

8 November 2017

33

1 reference

8 November 2017

6

1 reference

8 November 2017

689-695

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-010-9224-1

8 November 2017

0 references

cites work

Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

1 reference

12 December 2020

PKU adults and their return to diet: predicting diet continuation and maintenance

1 reference

12 December 2020

Living with phenylketonuria: perspectives of patients and their families

1 reference

12 December 2020

How practical are recommendations for dietary control in phenylketonuria?

1 reference

12 December 2020

Diet and compliance in phenylketonuria

1 reference

12 December 2020

Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria

1 reference

12 December 2020

Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria

1 reference

12 December 2020

Phenylketonuria--the lived experience

1 reference

12 December 2020

Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria

1 reference

12 December 2020

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

1 reference

12 December 2020

10.1007/S10545-010-9224-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 November 2017

0 references

1 reference